About me
Dr. Quyen Tran is a Science Policy Analyst on CDER’s Rare Diseases Team. Dr. Tran joined the FDA in 2017 and has worked in the Office of New Drugs and Office of Medical Policy, CDER. She has notable experience in rare disease drug development, policy development and implementation, regulatory operations, and knowledge management initiatives. Prior to joining the FDA, Dr. Tran worked at the National Cancer Institute and received her Doctorate of Pharmacy from the University of Maryland.
